ENTITY
Chugai Pharmaceutical

Chugai Pharmaceutical (4519 JP)

140
Analysis
Health Care ā€¢ Japan
Chugai Pharmaceutical Company Ltd., manufactures and sells pharmaceuticals in the domestic and international markets through its subsidiaries. The Company develops drugs in the fields of cancer, infectious diseases, bone, blood, and circulatory systems. Chugai Pharmaceutical also conducts research studies on drugs with private and public medical research institutions.
more
Refresh
ā€¢15 Dec 2019 13:59

šŸ‡ÆšŸ‡µ JAPAN ā€¢ December Sector & Peer Group Relative Price Scores - From Defensives to Cylicals

ā€¢ RELATIVE PRICE SCORE ā€¢RELATIVE PRICE SCORE OUTLIERS - The Relative Price Score (RPS) is a measure of price performance relative to TOPIX...

Logo
332 Views
Share
bullishā€¢MSCI World Index
ā€¢11 Dec 2019 07:37

Global Equities Headed Up and to the Right: Technology, Health Care Leading

Our weight of the evidence approach leads us to believe the market remains in the early stages of a broad-based advance, meaning a buy-the-dip...

Logo
446 Views
Share
ā€¢01 Nov 2019 20:34

Developed Markets Strategy: Stick with Japan

Despite EAFEā€™s YTD outperformance relative to EM, EAFE and EM returns have generally been equal since August, shown by the stalemate in the EAFE...

Logo
435 Views
Share
ā€¢30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believeĀ  developed international (EAFE) will remain in a leadership...

Logo
457 Views
Share
ā€¢06 Sep 2019 14:19

šŸ‡ÆšŸ‡µ Japan ā€¢ September Relative Price Scores - Life at the Poles Part 2: Companies

ā€¢ RELATIVEĀ PRICE SCOREĀ ā€¢INTRODUCTIONĀ - The Relative Price Score (RPS) is a measure of stock price performance relative to TOPIX calculated by...

Logo
511 Views
Share
x